Literature DB >> 28707055

Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.

Claudio De Vito1,2, Debashis Sarker3,4, Paul Ross4, Nigel Heaton5, Alberto Quaglia5.   

Abstract

Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare and aggressive primary liver cancer with both hepatocellular and cholangiocellular differentiation. Due to its bi-phenotypic component, cHCC-CC is a heterogeneous tumour and histopathological analysis of metastatic deposits is poorly characterized. In this retrospective study, we describe four patients in whom the histology from resected specimens of both primary and recurrent and/or metastatic tumour was available for comparison and immunohistochemical characterization. Our study shows that recurrent or metastatic deposits replicate the heterogeneity of the primary cHCC-CC, that even originally small foci of divergent differentiation can become predominant later on and that hepatocellular and cholangiocellular components can show different tropism in distant organs. In our experience, the behaviour of recurrent/metastatic cHCC-CC is unpredictable and histological examination is necessary to guide treatment options at present.

Entities:  

Keywords:  Combined hepatocellular-cholangiocarcinoma; Heterogeneity; Metastasis

Mesh:

Year:  2017        PMID: 28707055     DOI: 10.1007/s00428-017-2196-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

1.  Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.

Authors:  Dominique Cazals-Hatem; Sandra Rebouissou; Paulette Bioulac-Sage; Olivier Bluteau; Hélène Blanché; Dominique Franco; Geneviève Monges; Jacques Belghiti; Antonio Sa Cunha; Pierre Laurent-Puig; Claude Degott; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2004-08       Impact factor: 25.083

2.  Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.

Authors:  Chikako Zen; Yoh Zen; Ragai R Mitry; Denis Corbeil; Jana Karbanová; John O'Grady; John Karani; Pauline Kane; Nigel Heaton; Bernard C Portmann; Alberto Quaglia
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

3.  Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.

Authors:  Yunosuke Nishihara; Shinichi Aishima; Yousuke Kuroda; Tomohiro Iguchi; Kenichi Taguchi; Yoshiki Asayama; Akinobu Taketomi; Naoko Kinukawa; Hiroshi Honda; Masazumi Tsuneyoshi
Journal:  J Gastroenterol Hepatol       Date:  2008-09-24       Impact factor: 4.029

4.  Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.

Authors:  J W Valle; J Furuse; M Jitlal; S Beare; N Mizuno; H Wasan; J Bridgewater; T Okusaka
Journal:  Ann Oncol       Date:  2013-12-18       Impact factor: 32.976

5.  Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.

Authors:  Brett E Johnson; Tali Mazor; Chibo Hong; Michael Barnes; Koki Aihara; Cory Y McLean; Shaun D Fouse; Shogo Yamamoto; Hiroki Ueda; Kenji Tatsuno; Saurabh Asthana; Llewellyn E Jalbert; Sarah J Nelson; Andrew W Bollen; W Clay Gustafson; Elise Charron; William A Weiss; Ivan V Smirnov; Jun S Song; Adam B Olshen; Soonmee Cha; Yongjun Zhao; Richard A Moore; Andrew J Mungall; Steven J M Jones; Martin Hirst; Marco A Marra; Nobuhito Saito; Hiroyuki Aburatani; Akitake Mukasa; Mitchel S Berger; Susan M Chang; Barry S Taylor; Joseph F Costello
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

6.  Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

Authors:  Kathryn J Fowler; Arman Sheybani; Rex A Parker; Sean Doherty; Elizabeth M Brunt; William C Chapman; Christine O Menias
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

Review 7.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

Review 8.  Management of combined hepatocellular and cholangiocarcinoma.

Authors:  W T Kassahun; J Hauss
Journal:  Int J Clin Pract       Date:  2008-02-13       Impact factor: 2.503

9.  Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer.

Authors:  C-H Gow; Y-L Chang; Y-C Hsu; M-F Tsai; C-T Wu; C-J Yu; C-H Yang; Y-C Lee; P-C Yang; J-Y Shih
Journal:  Ann Oncol       Date:  2008-12-16       Impact factor: 32.976

10.  Intratumoral sampling variability in hepatocellular carcinoma: a case report.

Authors:  Giancarlo Senes; Daniela Fanni; Alessandro Cois; Alessandro Uccheddu; Gavino Faa
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

View more
  8 in total

1.  cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Authors:  Elizabeth Brunt; Shinichi Aishima; Pierre-Alain Clavien; Kathryn Fowler; Zachary Goodman; Gregory Gores; Annette Gouw; Alex Kagen; David Klimstra; Mina Komuta; Fukuo Kondo; Rebecca Miksad; Masayuki Nakano; Yasuni Nakanuma; Irene Ng; Valerie Paradis; Young Nyun Park; Alberto Quaglia; Massimo Roncalli; Tania Roskams; Michiie Sakamoto; Romil Saxena; Christine Sempoux; Claude Sirlin; Ashley Stueck; Swan Thung; W M S Tsui; Xin-Wei Wang; Aileen Wee; Hirohisa Yano; Matthew Yeh; Yoh Zen; Jessica Zucman-Rossi; Neil Theise
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

2.  Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients.

Authors:  Minjae Kim; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Seung-Mo Hong
Journal:  Ann Surg Treat Res       Date:  2021-04-29       Impact factor: 1.859

Review 3.  Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.

Authors:  Alberto Quaglia
Journal:  J Hepatocell Carcinoma       Date:  2018-11-08

4.  Breast Metastasis From a Combined Hepatocellular-Cholangiocarcinoma.

Authors:  Marco Silva; Rosa Coelho; Elisabete Rios; Sara Gomes; Fátima Carneiro; Guilherme Macedo
Journal:  ACG Case Rep J       Date:  2019-04-08

5.  Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.

Authors:  Takamichi Ishii; Takashi Ito; Shinji Sumiyoshi; Satoshi Ogiso; Ken Fukumitsu; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg Oncol       Date:  2020-12-04       Impact factor: 2.754

6.  Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma.

Authors:  Minjae Kim; Shin Hwang; Gi-Won Song; Chul-Soo Ahn; Deok-Bog Moon; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2021-01-11

Review 7.  Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms.

Authors:  Prodromos Hytiroglou; Paulette Bioulac-Sage; Neil D Theise; Christine Sempoux
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

Review 8.  Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.

Authors:  Joon Hyuk Choi; Jae Y Ro
Journal:  Biomedicines       Date:  2022-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.